Plasma Protein Therapeutics Association: Keeping Plasma and Patients Safe


Want a discount? Become a member by purchasing Corporate Membership, Enterprise Corporate Membership or Individual Membership!



Jointly provided by Partners for Advancing Clinical Education (PACE) and Ig National Society, Inc.

Original Release Date: February 2021
Last Review Date: January 2024
Expiration Date:  January 2025

Speaker: Amy Efantis

Continuing Education: Nursing .75 contact hour | Pharmacy .75 contact hour |  Physician .75 AMA PRA Category 1 Credit(s)™

Recertification: 1 IgCN® / IgCP® Recertification Units

Target Audience

This activity is intended for physicians, nurses, pharmacists, and other healthcare professionals who care for patients in need of immunoglobulin therapy and specialty biologics.

Educational Objectives                                                   

Upon completion of this activity, participants should be able to:

  • Describe the mission of the Plasma Protein Therapeutics Association as a trade association and a standards-setting body
  • Explain the safety of plasma protein therapies and the diseases treated by plasma protein therapies
  • State three of the Advocacy & procedures used during the pandemic to ensure the safety & availability of plasma and plasma protein therapies